4.6 Article

Four novel variants identified in primary hyperoxaluria and genotypic and phenotypic analysis in 21 Chinese patients

Related references

Note: Only part of the references are listed.
Article Urology & Nephrology

Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial

Mini Michael et al.

Summary: The study evaluates the efficacy, safety, pharmacokinetics, and pharmacodynamics of lumasiran in patients with primary hyperoxaluria type 1 (PH1) and advanced kidney disease. Lumasiran significantly reduces POx and improves other pharmacodynamic parameters. The study supports the efficacy and safety of lumasiran in patients with PH1 and advanced kidney disease.

AMERICAN JOURNAL OF KIDNEY DISEASES (2023)

Review Urology & Nephrology

Perspectives in primary hyperoxaluria - historical, current and future clinical interventions

Kevin Shee et al.

Summary: Primary hyperoxalurias are a devastating family of diseases that eventually lead to end-stage renal disease. Current treatment paradigms are limited, but new therapeutics aim to target oxalate synthesis and metabolism pathways to reduce accumulation and deposition in the body.

NATURE REVIEWS UROLOGY (2022)

Article Pediatrics

The effect of lumasiran therapy for primary hyperoxaluria type 1 in small infants

Marie-Noelle Meaux et al.

Summary: This study describes the treatment outcomes of lumasiran therapy in 3 infants under 2 years of age. Lumasiran appears to be effective and well-tolerated in infants, but it does not completely prevent the onset of nephrocalcinosis in severe cases. Higher doses may be required in infants due to hepatic immaturity.

PEDIATRIC NEPHROLOGY (2022)

Article Pediatrics

Case Report: Sustained Efficacy of Lumasiran at 18 Months in Primary Hyperoxaluria Type 1

Benedetta Chiodini et al.

Summary: Lumasiran has shown to effectively reduce plasma oxalate and urinary excretion levels in patients with primary hyperoxaluria type 1, leading to clinical improvements and stable kidney function.

FRONTIERS IN PEDIATRICS (2022)

Article Biochemistry & Molecular Biology

Pre-mRNA splicing factor U2AF2 recognizes distinct conformations of nucleotide variants at the center of the pre-mRNA splice site signal

Eliezra Glasser et al.

Summary: This study reveals the flexibility of U2AF2 in recognizing polypyrimidine tracts of nascent transcripts and the tolerance of nucleotide substitutions at the central position of the Py tract. The results highlight the importance of RNA flexibility for protein recognition and provide insights into the relationship between splice site motifs and pre-mRNA splicing efficiencies.

NUCLEIC ACIDS RESEARCH (2022)

Article Chemistry, Physical

Dual-action silver functionalized nanostructured titanium against drug resistant bacterial and fungal species

Louisa Z. Y. Huang et al.

Summary: The presence of nanostructures and the addition of silver nanoparticles on titanium substrate significantly enhance its antimicrobial activity. However, nanostructures alone are insufficient to achieve a highly antimicrobial effect, and a dual-action physical and chemical antimicrobial approach is necessary.

JOURNAL OF COLLOID AND INTERFACE SCIENCE (2022)

Review Pharmacology & Pharmacy

Improving Treatment Options for Primary Hyperoxaluria

Bernd Hoppe et al.

Summary: Primary hyperoxalurias are rare genetic disorders that affect the glyoxylate metabolism in the liver, leading to increased oxalate production and potential kidney problems. Current treatments are limited, with vitamin B-6 and RNA interference medication being options for certain patients. Future treatments may include substrate reduction therapy, stem cell transplantation, and gene therapy.

DRUGS (2022)

Article Medicine, General & Internal

Infantile Primary Hyperoxaluria Type 1 Treated With Lumasiran in Twin Males

Khaled Aldabek et al.

Summary: This report presents a case of twin males with infantile PH1 who were successfully treated with lumasiran, leading to symptom relief and no disease progression.

CUREUS JOURNAL OF MEDICAL SCIENCE (2022)

Article Urology & Nephrology

Characteristics of the genotype and phenotype in Chinese primary hyperoxaluria type 1 populations

Fangzhou Zhao et al.

Summary: The study revealed heterogeneity between genotype and phenotype in Chinese PH1 patients, with c.815_816insGA and c.33_34insC identified as mutation hotspot regions in China associated with poor prognosis. The race-specific mutation c.1049G>A was not determined in Pakistani patients.

UROLITHIASIS (2021)

Article Urology & Nephrology

Clinical analysis of 13 children with primary hyperoxaluria type 1

Jin-ai Lin et al.

Summary: A retrospective statistical analysis of primary hyperoxaluria type 1 in children from June 2016 to May 2019 revealed that infant type is the most common and has higher mortality and renal failure rates. Nephrocalcinosis is an independent risk factor leading to renal insufficiency.

UROLITHIASIS (2021)

Article Surgery

Primary hyperoxaluria diagnosed after kidney transplant: A review of the literature and case report of aggressive renal replacement therapy and lumasiran to prevent allograft loss

Hillarey K. Stone et al.

Summary: Primary hyperoxaluria type 1 is a rare genetic disorder that can be easily missed and lead to poor outcomes post-transplant, highlighting the importance of early detection and intervention to prevent adverse consequences in patients with chronic kidney disease.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Letter Cardiac & Cardiovascular Systems

Oxalic Cardiomyopathy Could it Influence Treatment Plans in Patients With Primary Hyperoxaluria Type 1?

Alessandro Di Toro et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Article Urology & Nephrology

Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up

Sander F. Garrelfs et al.

KIDNEY INTERNATIONAL (2019)

Article Gastroenterology & Hepatology

Recipient characteristics and morbidity and mortality after liver transplantation

Sumeet K. Asrani et al.

JOURNAL OF HEPATOLOGY (2018)

Article Medicine, General & Internal

A Putative Mutation Hotspot of the AGXT Gene Associated with Primary Hyperoxaluria Type 1 in the Chinese Population

Xiyuan Li et al.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2018)

Review Endocrinology & Metabolism

ENDOCRINE MANIFESTATIONS OF PRIMARY HYPEROXALURIA

Shatha Murad et al.

ENDOCRINE PRACTICE (2017)

Article Urology & Nephrology

Two Novel HOGA1 Splicing Mutations Identified in a Chinese Patient with Primary Hyperoxaluria Type 3

Xinsheng Wang et al.

AMERICAN JOURNAL OF NEPHROLOGY (2015)

Article Urology & Nephrology

Vitamin B6 in Primary Hyperoxaluria I: First Prospective Trial after 40 Years of Practice

Heike Hoyer-Kuhn et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)

Article Urology & Nephrology

Mutational analysis of AGXT in two Chinese families with primary hyperoxaluria type 1

Guo-min Li et al.

BMC NEPHROLOGY (2014)

Review Urology & Nephrology

An update on primary hyperoxaluria

Bernd Hoppe

NATURE REVIEWS NEPHROLOGY (2012)

Article Transplantation

The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type 3

Emma L. Williams et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)

Article Urology & Nephrology

Primary Hyperoxaluria Type III Gene HOGA1 (Formerly DHDPSL) as a Possible Risk Factor for Idiopathic Calcium Oxalate Urolithiasis

Carla G. Monico et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)

Article Genetics & Heredity

Mutations in DHDPSL Are Responsible For Primary Hyperoxaluria Type III

Ruth Belostotsky et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2010)

Article Genetics & Heredity

Primary Hyperoxaluria Type 1: Update and Additional Mutation Analysis of the AGXT Gene

Emma L. Williams et al.

HUMAN MUTATION (2009)

Review Urology & Nephrology

The primary hyperoxalurias

Bernd Hoppe et al.

KIDNEY INTERNATIONAL (2009)

Article Medical Laboratory Technology

Mutation-based diagnostic testing for primary hyperoxaluria type 1: Survey of results

Marion B. Coulter-Mackie et al.

CLINICAL BIOCHEMISTRY (2008)

Article Biochemistry & Molecular Biology

In Vivo and in Vitro Examination of Stability of Primary Hyperoxaluria-associated Human Alanine: Glyoxylate Aminotransferase

Erin D. Hopper et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Review Urology & Nephrology

The primary hyperoxalurias

Amy E. Bobrowski et al.

SEMINARS IN NEPHROLOGY (2008)

Review Biochemistry & Molecular Biology

Structure-function relationships of the polypyrimidine tract binding protein

S. D. Auweter et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2008)

Article Urology & Nephrology

Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis

Carla G. Monico et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)

Article Endocrinology & Metabolism

Consequences of missense mutations for dimerization and turnover of alanine:glyoxylate aminotransferase:: Study of a spectrum of mutations

M. B. Coulter-Mackie et al.

MOLECULAR GENETICS AND METABOLISM (2006)

Review Endocrinology & Metabolism

Genetic heterogeneity in primary hyperoxaluria type 1: impact on diagnosis

MB Coulter-Mackie et al.

MOLECULAR GENETICS AND METABOLISM (2004)

Article Transplantation

Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome

CS van Woerden et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)

Article Endocrinology & Metabolism

Three novel deletions in the alanine: Glyoxylate aminotransferase gene of three patients with type 1 hyperoxaluria

MB Coulter-Mackie et al.

MOLECULAR GENETICS AND METABOLISM (2001)